EP Patent

EP2538924B1 — Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2014-05-21 · 12y expired

What this patent protects

Patent listed against Zyprexa.

Drugs covered by this patent

Patent Metadata

Patent number
EP2538924B1
Jurisdiction
EP
Classification
—
Expires
2014-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.